GOS‐Modulated Gut Microbiota in Mice Ameliorates Obesity in High‐Fat Diet‐Fed Mice Through the Gut‐Liver Axis and Bile Acid Pathway
Journal of Food Science · 2025
DOI: 10.1111/1750-3841.70361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Food Science, 2025. Verfasst von Jianxing Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Engineering Research Center of Natural Products and New Drugs, Guangdong Provincial University Engineering Technology Research Center of Na…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Bile Acids and Salts, Obesity, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: the Science and Technology Program of Guangzhou, China, the Guangdong Demonstration BASe for Joint Cultivation of Postgraduates (2023), the Science Foundation for Distinguished Young Scholars of Guangdong, China.
Abstract (Originalsprache)
This work is meant to study the effect of galacto‐oligosaccharide (GOS) intervention in the fecal microbiota of obese mice on lipid metabolism and anti‐obesity in mice. A pseudo‐germ‐free mice model was established by administration of a mixture of antibiotics. The fecal microbiota of GOS‐fed obese mice are transplanted into pseudo‐germ‐free mice. To investigate the effects of GOS intervention on lipid metabolism, lipid quadruple, bile acid metabolism, and intestinal microbiota in obese mice. At the same time, the expression of BAS synthase and the effects of FXR‐SHP and FXR‐FGF15‐FGFR4 signaling pathways on BAS homeostasis were also explored. The fecal microbiota of obese mice intervened by GOS could reshape the structure of intestinal microbiota, regulate the synthesis of bile acids in the enterohepatic circulation and the expression of transport‐related factors, and promote metabolic ability to exert anti‐obesity effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Engineering Research Center of Natural Products and New Drugs, Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs, Guangdong Pharmaceutical University, Guangzh…
- Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorder, Guangdong TCM Key Laboratory for Metabolic Diseases, Ministry of Education of Chin…
- School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China.
- Guangzhou Rainhome Pharm & Tech Co., Ltd., Science City, Guangzhou, China.
- School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, Zhongshan, China.
ORCID-Profile: Zhengquan Su
Förderung
- the Science and Technology Program of Guangzhou, China
- the Guangdong Demonstration BASe for Joint Cultivation of Postgraduates (2023)
- the Science Foundation for Distinguished Young Scholars of Guangdong, China
Zitieren
APA
Wu, J., Xiang, J., Song, P., Bai, Y., Che, Q., Cao, H., Guo, J., & Su, Z. (2025). GOS‐Modulated Gut Microbiota in Mice Ameliorates Obesity in High‐Fat Diet‐Fed Mice Through the Gut‐Liver Axis and Bile Acid Pathway. Journal of Food Science. https://doi.org/10.1111/1750-3841.70361
Vancouver
Wu J, Xiang J, Song P, Bai Y, Che Q, Cao H, et al. GOS‐Modulated Gut Microbiota in Mice Ameliorates Obesity in High‐Fat Diet‐Fed Mice Through the Gut‐Liver Axis and Bile Acid Pathway. Journal of Food Science. 2025. doi:10.1111/1750-3841.70361
BibTeX
@article{Wu2025,
author = {Wu, Jianxing and Xiang, Junwei and Song, Pan and Bai, Yan and Che, Qishi and Cao, Hua and Guo, Jiao and Su, Zhengquan},
title = {GOS‐Modulated Gut Microbiota in Mice Ameliorates Obesity in High‐Fat Diet‐Fed Mice Through the Gut‐Liver Axis and Bile Acid Pathway},
journal = {Journal of Food Science},
year = {2025},
doi = {10.1111/1750-3841.70361}
}
EUVIMED